Genesis of a KPC-producing Klebsiella pneumoniae after in vivo transfer from an imported Greek strain

Eurosurveillance

Volumn 15, Issue 1, 2010, Pages 1-3

  Barbier, F ^a   Ruppe E ^a   Giakkoupi, P ^b   Wildenberg, L ^a   Lucet, J C ^a   Vatopoulos, A ^b   Wolff, M ^a   Andremont, A ^a  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^b NATIONAL SCHOOL OF PUBLIC HEALTH   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AZTREONAM; CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; COTRIMOXAZOLE; DORIPENEM; ERTAPENEM; GENTAMICIN; IMIPENEM; MEROPENEM; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; TIGECYCLINE; TOBRAMYCIN; BETA LACTAMASE; BETA LACTAMASE KPC 2, KLEBSIELLA PNEUMONIAE; BETA-LACTAMASE KPC-2, KLEBSIELLA PNEUMONIAE; CARBAPENEM DERIVATIVE;

AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; CASE REPORT; CATHETER INFECTION; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING KLEBSIELLA PNEUMONIAE; HEMORRHAGIC SHOCK; HUMAN; INTESTINAL BLEEDING; KLEBSIELLA PNEUMONIAE CARBAPENEMASE PRODUCING KLEBSIELLA PNEUMONIAE; KLEBSIELLA PNEUMONIAE INFECTION; MALE; MINIMUM INHIBITORY CONCENTRATION; MULTIPLE ORGAN FAILURE; POLYMERASE CHAIN REACTION; ANTIBIOTIC RESISTANCE; BACTERIUM TRANSFORMATION; CATHETERIZATION; CROSS INFECTION; FRANCE; GENETICS; GREECE; INTENSIVE CARE UNIT; ISOLATION AND PURIFICATION; KLEBSIELLA INFECTION; KLEBSIELLA PNEUMONIAE;

AGED; BETA-LACTAMASES; CARBAPENEMS; CATHETERIZATION; CROSS INFECTION; DRUG RESISTANCE, BACTERIAL; FRANCE; GREECE; HUMANS; INTENSIVE CARE UNITS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MALE; TRANSFORMATION, BACTERIAL;

EID: 77952504083     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: 10.2807/ese.15.01.19457-en     Document Type: Article

References (7)

1. Nordmann P, Cuzon G, Naas T. The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infect Dis. 2009;9(4):228-36.
2. Naas T, Cuzon G, Villegas MV, Lartigue MF, Quinn JP, Nordmann P. Genetic structures at the origin of acquisition of the beta-lactamase blaKPC gene. Antimicrob Agents Chemother. 2008;52(4):1257-63.
3. Cai JC, Zhou HW, Zhang R, Chen GX. Emergence of Serratia marcescens, Klebsiella pneumoniae, and Escherichia coli isolates possessing the plasmid-mediated carbapenemhydrolyzing beta-lactamase KPC-2 in intensive care units of a Chinese hospital. Antimicrob Agents Chemother. 2008;52(6):2014-8.
4. Rasheed JK, Biddle JW, Anderson KF, Washer L, Chenoweth C, Perrin J, et al. Detection of the Klebsiella pneumoniae carbapenemase type 2 Carbapenem-hydrolyzing enzyme in clinical isolates of Citrobacter freundii and K. oxytoca carrying a common plasmid. J Clin Microbiol. 2008;46(6):2066-9.
5. European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 1.0 December 2009. Available from: http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Disk_test_documents/EUCAST_breakpoints_v1.0_20091221.pdf
6. Giakkoupi P, Pappa O, Polemis M, Vatopoulos AC, Miriagou V, Zioga A, et al. Emerging Klebsiella pneumoniae isolates coproducing KPC-2 and VIM-1 carbapenemases. Antimicrob Agents Chemother. 2009;53(9):4048-50.
7. Giakoupi P, Maltezou H, Polemis M, Pappa O, Saroglou G, Vatopoulos A, et al. KPC-2-producing Klebsiella pneumoniae infections in Greek hospitals are mainly due to a hyperepidemic clone. Euro Surveill. 2009;14(21):pii=19218. Available from: http://www.eurosurveillance.org